More details
Fact Sheet
Iron Infusion with ferric carboxymaltose (FCM)
- for the treatment of iron deficiency conditions such as iron deficiency anaemia

Iron infusion with ferric carboxymaltose (FCM)*


Overview

An iron infusion is a minor procedure when an iron containing medicine is infused directly into the blood circulation. The iron containing preparation circulates and is delivered to the body organs that require iron for normal functioning.

Ferric carboxymaltose (FCM) also known as FERINJECT® is an intravenous (IV) iron preparation, a medicine that is used in the treatment of iron deficiency conditions such as iron-deficiency anaemia (IDA). It contains iron in the form of ferric carboxymaltose, an iron carbohydrate compound.

Iron is an essential element required for the oxygen-carrying capacity of haemoglobin in red blood cells and of myoglobin in muscle tissue. Moreover, iron plays an important role in many other vital processes in the human body.

In particular, Ferric carboxymaltose (FCM) is an iron preparation that has characteristics that allow larger single doses to be administered over a shorter infusion period compared with previously used IV iron preparations.

When is an iron infusion recommended?

Iron deficiency is a common cause of anaemia.

In Australia current clinical management recommends use of oral iron (in appropriate doses and for sufficient duration) as first-line therapy for most patients presenting with of iron-deficiency anaemia (IDA).

An iron infusion is sometimes recommended for people who are low in iron (iron deficient). Usually iron can be given orally but sometimes patients experience side-effects from oral iron (stomach upsets, constipation) or there are situations when oral iron is ineffective or cannot be used, and an iron infusion may be recommended.

If the body iron is particularly low, an iron infusion may be recommended to increase the iron stores quickly.

The aim of the iron infusion therapy is to replenish body iron stores and to remedy anaemia, a reduced level of haemoglobin due to iron deficiency.

Potential Risks &/or Side Effects

Are iron infusions safe?

It is generally recommended that iron therapy initially be given orally. Iron infusions are however considered safe particularly with the newer iron containing preparations currently available.

In the past (older) iron infusions were associated with common side-effects including allergic type reactions. This is much less common with the current iron containing preparation (Ferric carboxymaltose FCM also known as FERINJECT®) but this is still a potential risk. Your doctor will talk to you about the risks and the benefits of having an iron infusion in your particular circumstances.

What are the side-effects of an iron infusion with FCM?

It is unusual to experience any significant side-effects from an iron infusion with the newer iron containing medications.

Some patients may experience a headache or feel nauseated. Less commonly some patients experience flushing, a disturbance in taste, itchiness, fever and chills.

Please see the full list of side-effects of iron infusions (Ferinject) given to you by your doctor.

Iron Infusion Procedure

What do I need to do on the day of the iron infusion?

There is no particular preparation needed for the iron infusion.

It is helpful if you have had plenty of fluids to drink so finding a vein for the infusion can be easier.

You will be able to drive home after the iron infusion.

How long does the iron infusion take?

The infusion usually only takes 15 – 20 minutes once the IV drip infusion is commenced.

Is there anything I need to do after the iron infusion?

After your Iron Infusion

It’s is always important to monitor your own health after an iron infusion. If you experience any significant symptoms (for example chest pain or difficulty breathing) it will be important for you to contact your doctor who administered the iron infusion or an emergency department as soon as possible.

Dummy Image

How common is Hereditary Spherocytosis (HS)?

HS is relatively common – around 1 person in every 5000 people has HS (around 800 people in Melbourne; population 4 million).

0

in 5000 people has HS

Which is the same as

0

people in Melbourne

0

population of Melbourne*


What does having HS mean?

There are three main common problems associated with having HS:

01.

Anaemia

– this occurs because the red cells break down more quickly

02.

Jaundice

– when red cells break down they release a pigment called bilirubin which appears as a yellow colour in the skin and the eyes. Over a long period of time, the problem of jaundice can be associated with gall stones.

03.

Increase in the size of the spleen

– this is the site of the red cells breaking down. The spleen is a blood filter and some of the red cells can get caught up in the spleen

There is another uncommon potential problem for people who have Hereditary Spherocytosis associated with a viral infection called “Slapped cheek”. Slapped cheek is caused by a virus called Parvovirus which can infect bone marrow cells and put the red cell producing cells “to sleep”. Because patients with HS need the bone marrow to be rapidly replacing the fragile red cells, this infection can cause a severe anaemia; patients can become very pale and sometimes even require blood transfusions. Fortunately this problem is uncommon.


Diagnosis

How is Hereditary Spherocytosis diagnosed?

HS is now diagnosed with a simple blood test. It is also important for a doctor to examine patients with HS to see if they are jaundiced or have an increase in the size of the spleen.


Treatment & Management

What do I need to do now that I (or my child) has been diagnosed with Hereditary Spherocytosis?

Most patients with HS do not need to do much about their condition at all. The bone marrow has the capacity to increase the number of red cells it produces many fold and is able to keep up replacing the fragile cells.

A few things may be helpful:

01.

Regular blood tests

– to check on the level of haemolysis

02.

Folate supplementation

An important vitamin necessary for the bone marrow to function properly is folate. Folate is found in green leafy vegetables. Most people get enough folate in their diet but getting extra folate (particularly in HS if there is significant haemolysis – red cell breakdown) is generally recommended.

03.

Ultrasounds to exclude gall stones

It may also be important to make sure children and adults are not developing gall stones – an ultrasound of the gall bladder after that age of 5 years of age every 3 – 5 years there after, is the current recommendation.

Will I (or my child) need a splenectomy?

Removing the spleen (splenectomy) has been used a lot in the past in the treatment and management of patients with HS; it stops the red cells from breaking down and solves the problems of HS.

Removing the spleen has problems however – the spleen is an important organ in the immune system and patients who do not have a spleen may be prone to getting serious infections. This risk is higher in younger children but may be less than previously expected because of newer vaccinations. It is now generally recommended to avoid splenectomy in children younger than 6 years and to ensure that children who may need a splenectomy have all the appropriate vaccinations.

Another approach for some of these young patients is to remove only a small part of the spleen – partial splenectomy. This is done in a few hospitals and there is some experience to say this may be very helpful for some patients.


Resources used to produce this information sheet.

  1. https://www.mja.com.au/journal/2010/193/9/diagnosis-and-management-iron-deficiency-anaemia-clinical-update
  2. http://www.nps.org.au/medicines/hormonal-and-metabolic-system/red-blood-cell-production-medicines/ferriccarboxymaltose/
    ferinject-solution-for-injection
  3. http://www.nps.org.au/publications/health-professional/nps-radar/2014/august-2014/ferric-carboxymaltose


Further Questions?

The information presented in this fact sheet is intended as a general guide only.

Patients should seek further advice and information about an Iron Infusion with ferric carboxymaltose (FCM) and their individual condition from their treating haematologist or doctor.

1000 563 Melbourne Haematology
Start Typing
Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

For performance and security reasons we use Cloudflare
required
Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.